Select a product below to learn more about how INSUPPORT can help you.
Please see the full Prescribing Information including BOXED WARNING, Important Safety Information and Medication Guide for SUBLOCADE™ (buprenorphine extended-release) injection, for subcutaneous use (CIII).
Because of the serious risk of potential harm or death from self-injecting SUBLOCADE into a vein (intravenously), it is only available through a restricted program called the SUBLOCADE REMS Program.
- SUBLOCADE is not available in retail pharmacies.
- Your SUBLOCADE injection will only be given to you by a certified healthcare provider.
Please see the full Prescribing Information including BOXED WARNING and Important Safety Information for PERSERIS™ (risperidone) for extended-release injectable suspension.
Drugs like PERSERIS that are used to treat schizophrenia can cause serious side effects, including an increased risk of death in elderly people who are confused, have memory loss, and have lost touch with reality (dementia-related psychosis). PERSERIS is not approved to treat dementia-related psychosis and it has not been studied in elderly people with dementia-related psychosis.
Do not receive PERSERIS if you are allergic to risperidone, paliperidone, or to any of its components.